Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Transplantation
    November 2017
  1. GRODSTEIN EI, Baggett N, Wayne S, Leverson G, et al
    An Evaluation of the Safety and Efficacy of Simultaneous Bilateral Nephrectomy and Renal Transplantation for Polycystic Kidney Disease: A 20-Year Experience.
    Transplantation. 2017;101:2774-2779.
    >> Share

    October 2017
  2. GREEN H, Lichtenberg S, Rahamimov R, Livneh A, et al
    Familial Mediterranean Fever Is Associated With Increased Mortality After Kidney Transplantation-A 19 Years' Single Center Experience.
    Transplantation. 2017;101:2621-2626.
    >> Share

  3. CHANDAK P, Kessaris N, Callaghan CJ, Calder F, et al
    Insights in Transplanting Complex Pediatric Renal Recipients With Vascular Anomalies.
    Transplantation. 2017;101:2562-2570.
    >> Share

    September 2017
  4. GEORGE RP
    Urinary biomarker CXCL10, identifying site specific allograft inflammation in renal transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001960.
    >> Share

  5. SCHMIDT BMW, Sugianto RI, Thurn D, Azukaitis K, et al
    Early effects of renal replacement therapy on cardiovascular comorbidity in children with end-stage kidney disease: findings from the 4C-T Study.
    Transplantation. 2017 Sep 18. doi: 10.1097/TP.0000000000001948.
    >> Share

  6. HO J, Schaub S, Wiebe C, Gao A, et al
    Urinary CXCL10 chemokine is associated with alloimmune and virus compartment-specific renal allograft inflammation.
    Transplantation. 2017 Sep 12. doi: 10.1097/TP.0000000000001931.
    >> Share

  7. SAWINSKI D, Lim MA, Cohen JC, Locke JE, et al
    Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001930.
    >> Share

  8. AVETTAND-FENOEL V, Rouzioux C, Legendre C, Canaud G, et al
    HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation.
    Transplantation. 2017;101:2003-2008.
    >> Share

    August 2017
  9. LEVI C, Fremeaux-Bacchi V, Zuber J, Rabant M, et al
    Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
    Transplantation. 2017 Aug 25. doi: 10.1097/TP.0000000000001909.
    >> Share

    July 2017
  10. PETERS-SENGERS H, Heemskerk MBA, Geskus RB, Kers J, et al
    Validation of the Prognostic Kidney Donor Risk Index (KDRI) Scoring System of Deceased Donors for Renal Transplantation in the Netherlands.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001889.
    >> Share

    June 2017
  11. FELTRAN LS, Varela P, Silva ED, Veronez CL, et al
    Targeted Next-generation Sequencing in Brazilian Children With Nephrotic Syndrome Submitted to Renal Transplant.
    Transplantation. 2017 Jun 28. doi: 10.1097/TP.0000000000001846.
    >> Share

  12. RAMESSUR CHANDRAN S, Han Y, Tesch GH, Di Paolo J, et al
    Inhibition of spleen tyrosine kinase reduces renal allograft injury in a rat model of acute antibody-mediated rejection in sensitized recipients.
    Transplantation. 2017 Jun 7. doi: 10.1097/TP.0000000000001826.
    >> Share

  13. CHHABRA AY, Leventhal J, Merchak AR, Ildstad S, et al
    HSCT Based Approaches for Tolerance Induction in Renal Transplant.
    Transplantation. 2017 Jun 1. doi: 10.1097/TP.0000000000001837.
    >> Share

  14. MOLNAR MZ, Nguyen DV, Chen Y, Ravel V, et al
    Predictive Score for Posttransplantation Outcomes.
    Transplantation. 2017;101:1353-1364.
    >> Share

    April 2017
  15. EGELAND EJ, Robertsen I, Hermann M, Midtvedt K, et al
    High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation.
    Transplantation. 2017 Apr 27. doi: 10.1097/TP.0000000000001796.
    >> Share

  16. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    >> Share

  17. CHITTKA D, Hutchinson JA
    Pregnancy After Renal Transplantation.
    Transplantation. 2017;101:675-678.
    >> Share

  18. JAY CL, Washburn K, Dean PG, Helmick RA, et al
    Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys.
    Transplantation. 2017;101:867-872.
    >> Share

    March 2017
  19. LAHAM G, Soler Pujol G, Vilches A, Cusumano A, et al
    Nonprogrammed vascular access is associated with greater mortality in patients who return to hemodialysis with a failing renal graft.
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001751.
    >> Share

  20. STEWART DE, Garcia VC, Rosendale JD, Klassen DK, et al
    Diagnosing the Decades-Long Rise in the Deceased Donor Kidney Discard Rate in the United States.
    Transplantation. 2017;101:575-587.
    >> Share

    February 2017
  21. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    >> Share

  22. DAHLE DO, Grotmol T, Leivestad T, Hartmann A, et al
    Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.
    Transplantation. 2017 Feb 15. doi: 10.1097/TP.0000000000001659.
    >> Share

  23. O'SHAUGHNESSY MM, Liu S, Montez-Rath ME, Lafayette RA, et al
    Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
    Transplantation. 2017 Feb 15. doi: 10.1097/TP.0000000000001657.
    >> Share

  24. ROBERTS V, Campbell DJ, Lu B, Chia J, et al
    The differential effect of apyrase treatment and hCD39 overexpression on chronic renal fibrosis following ischemia reperfusion injury.
    Transplantation. 2017 Feb 14. doi: 10.1097/TP.0000000000001679.
    >> Share

    January 2017
  25. MARTENS GR, Reyes LM, Butler JR, Ladowski JM, et al
    Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells from GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001646.
    >> Share

  26. PICCOLI GB, Cabiddu G, Attini R, Gerbino M, et al
    Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001645.
    >> Share

  27. YAZDANI S, Naesens M
    Foretelling Graft Outcome by Molecular Evaluation of Renal Allograft Biopsies: The GoCAR Study.
    Transplantation. 2017;101:5-7.
    >> Share

    December 2016
  28. WAISER J, Duerr M, Budde K, Rudolph B, et al
    Treatment of Acute Antibody-Mediated Renal Allograft Rejection with Cyclophosphamide.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001617.
    >> Share

  29. LUBETZKY M, Chun S, Joelson A, Coco M, et al
    Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001618.
    >> Share

  30. REKERS NV, Flaig TM, Mallat MJ, Spruyt-Gerritse MJ, et al
    Donor genotype and intragraft expression of CYP3A5 reflect the response to steroid treatment during acute renal allograft rejection.
    Transplantation. 2016.
    >> Share

  31. LONNING K, Midtvedt K, Leivestad T, Reisaeter AV, et al
    Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Transplantation. 2016;100:2705-2709.
    >> Share

  32. OSHIMA S, Karrer EE, Kawato Y, Maeda M, et al
    The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
    Transplantation. 2016;100:2611-2620.
    >> Share

  33. SUTHERLAND AI
    Renal Transplantation in OCTOGENARIANS-A Real Proposition?
    Transplantation. 2016;100:2519-2520.
    >> Share

    October 2016
  34. DAVID-NETO E, Agena F, Ramos F, Triboni AH, et al
    Longitudinal Pharmacokinetics of Everolimus when Combined with Low-level of Tacrolimus in Elderly Renal Transplant Recipients.
    Transplantation. 2016.
    >> Share

  35. MCADAMS-DEMARCO MA, Ying H, Olorundare I, King EA, et al
    Individual Frailty Components and Mortality In Kidney Transplant Recipients.
    Transplantation. 2016.
    >> Share

  36. ZALTZMAN JS
    Is there a role for mTOR inhibitors in renal transplantation?
    Transplantation. 2016.
    >> Share

    September 2016
  37. CHEN L, Liberatore L, Chin T, Walker S, et al
    The Impact of Total Gastrectomy on Pharmacokinetics in Kidney Transplant Immunosuppressive Drug Regimes: A Case Study.
    Transplantation. 2016.
    >> Share

  38. BAMOULID J, Roodenburg A, Staeck O, Wu K, et al
    Clinical Outcome of Patients with De Novo C1q-Binding Donor-Specific HLA Antibodies after Renal Transplantation.
    Transplantation. 2016.
    >> Share


  39. Prevalence and Risk Factors of Noncontrolled and Resistant Arterial Hypertension in Renal Transplant Recipients: Erratum.
    Transplantation. 2016;100:e54.
    >> Share


  40. Antithymocyte Globulin is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients: Erratum.
    Transplantation. 2016;100:e54.
    >> Share

  41. HIRT-MINKOWSKI P, Rush DN, Gao A, Hopfer H, et al
    Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
    Transplantation. 2016;100:1988-96.
    >> Share

    August 2016
  42. PERRIN P, Kiener C, Javier RM, Braun L, et al
    Recent changes in chronic kidney disease-mineral and bone disorders (CKD-MBD) and associated fractures after kidney transplantation.
    Transplantation. 2016.
    >> Share

  43. KIM IK, Choi J, Vo AA, Kang A, et al
    Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Transplantation. 2016.
    >> Share

  44. CHOW KV, Flint SM, Shen A, Landgren A, et al
    Histological and Extended Clinical Outcomes Following ABO-incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Transplantation. 2016.
    >> Share

  45. EISENBERGER U, Guberina H, Willuweit K, Bienholz A, et al
    Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients.
    Transplantation. 2016.
    >> Share

  46. SOARES KC, Arend LJ, Lonze BE, Desai NM, et al
    Successful Renal Transplantation of Deceased Donor Kidneys With 100% Glomerular Fibrin Thrombi and Acute Renal Failure Due To Disseminated Intravascular Coagulation.
    Transplantation. 2016.
    >> Share

  47. BONANI M, Pereira RM, Misselwitz B, Fehr T, et al
    Chronic norovirus infection as a risk factor for secondary lactose maldigestion in renal transplant recipients: a prospective parallel cohort pilot study.
    Transplantation. 2016.
    >> Share

  48. DAVID-NETO E, Romano P, Triboni AH, Ramos F, et al
    Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared to Younger recipients in the first 6 months after renal transplantation.
    Transplantation. 2016.
    >> Share

  49. SUTHERLAND A
    Renal transplantation in Octogenarians - a real proposition?
    Transplantation. 2016.
    >> Share

  50. FREEMAN MA, Pleis JR, Bornemann K, Croswell E, et al
    Has the Department of Veterans Affairs found a way to avoid racial disparities in the evaluation process for kidney transplantation?
    Transplantation. 2016.
    >> Share

  51. KABORE R, Couchoud C, Macher MA, Salomon R, et al
    Age dependent risk of graft failure in young kidney transplant recipients.
    Transplantation. 2016.
    >> Share

    July 2016
  52. SEGALL L, Nistor I, Pascual J, Mucsi I, et al
    Criteria For And Appropriateness Of Renal Transplantation In Elderly Patients With End-Stage Renal Disease: A Literature Review And Position Statement On Behalf Of The European Renal Association-European Dialysis And Transplant Association Descartes W
    Transplantation. 2016.
    >> Share

  53. LONNING K, Midtvedt K, Leivestad T, Reisaeter AV, et al
    Are octogenarians with end stage renal disease candidates for renal transplantation?
    Transplantation. 2016.
    >> Share

  54. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    >> Share

  55. ELDER GJ
    Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism; who's conducting the orchestra?
    Transplantation. 2016.
    >> Share

  56. SAWINSKI D, Lee DH, Doyle AM, Blumberg EA, et al
    Successful Posttransplant Treatment of Hepatitis C with Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients.
    Transplantation. 2016.
    >> Share

  57. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Nogues X, et al
    Bone density, microarchitecture and tissue quality long-term after kidney transplant.
    Transplantation. 2016.
    >> Share

  58. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    >> Share

  59. EVENEPOEL P, Claes K, Viaene L, Bammens B, et al
    Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Transplantation. 2016.
    >> Share

    June 2016
  60. LOLLINGA WT, de Wit RH, Rahbar A, Vasse GF, et al
    Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.
    Transplantation. 2016.
    >> Share

  61. CRESPO E, Roedder S, Sigdel T, Hsieh SC, et al
    Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    Transplantation. 2016.
    >> Share

  62. LINDAHL JP, Massey RJ, Hartmann A, Aakhus S, et al
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation.
    Transplantation. 2016.
    >> Share

    May 2016
  63. LIU S, Chaudhry MR, Berrebi AA, Papadimitriou JC, et al
    Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation.
    Transplantation. 2016.
    >> Share

  64. HELLSTROM V, Lorant T, Dohler B, Tufveson G, et al
    High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer.
    Transplantation. 2016.
    >> Share

    April 2016
  65. O'REGAN JA, Prendeville S, McCaughan JA, Traynor C, et al
    Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    Transplantation. 2016.
    >> Share

  66. FRANK SJ, Walter WR, Latson L Jr, Cohen HW, et al
    New Dimensions in Renal Transplant Sonography: Applications of 3-Dimensional Ultrasound.
    Transplantation. 2016 Apr 21. doi: 10.1097/TP.0000000000001206.
    >> Share

  67. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    >> Share

    March 2016
  68. DE LIMA JJ, Gowdak LH, de Paula FJ, Muela HC, et al
    Coronary Artery Disease Assessment and Intervention in Renal Transplant Patients: Analysis from the KiHeart Cohort.
    Transplantation. 2016.
    >> Share

  69. ALHAMAD T, Brennan DC, Brifkani Z, Xiao H, et al
    Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications after Kidney Transplantation.
    Transplantation. 2016.
    >> Share

  70. VISENTIN J, Ramaharo D, Ryman A, Contin-Bordes C, et al
    Prevalence of IgA Antibodies to beta2-Glycoprotein I: A Population-Dependent Feature?
    Transplantation. 2016;100:e13-4.
    >> Share

    February 2016
  71. WYLD ML, Chadban SJ
    Recurrent IgA Nephropathy After Kidney Transplantation.
    Transplantation. 2016.
    >> Share

  72. NEWMAN KL, Fedewa SA, Jacobson MH, Adams AB, et al
    Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End-Stage Renal Disease Patients.
    Transplantation. 2016.
    >> Share

  73. COZZI E, Biancone L, Lopez-Fraga M, Nanni-Costa A, et al
    Long-term Outcome of Living Kidney Donation: Position Paper of the European Committee on Organ Transplantation, Council of Europe.
    Transplantation. 2016;100:270-1.
    >> Share

  74. CANAUD G, Delville M, Legendre C
    Recurrence of Focal and Segmental Glomerulosclerosis After Transplantation.
    Transplantation. 2016;100:284-7.
    >> Share

  75. CLAYTON PA
    Risky Business-Is the RoCKeT Ready to fly?
    Transplantation. 2016;100:268-9.
    >> Share

    November 2015
  76. MOLNAR MZ, Ravel V, Streja E, Kovesdy CP, et al
    Racial Differences in Survival of Incident Home Hemodialysis and Kidney Transplant Patients.
    Transplantation. 2015.
    >> Share

  77. SHIN JI, Palta M, Djamali A, Kaufman DB, et al
    The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Transplantation. 2015.
    >> Share

    October 2015
  78. LAGING M, Kal-van Gestel JA, van de Wetering J, IJzermans JN, et al
    A High Comorbidity Score Should Not be a Contraindication for Kidney Transplantation.
    Transplantation. 2015.
    >> Share

    September 2015
  79. GATHOGO E, Harber M, Bhagani S, Levy J, et al
    Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Transplantation. 2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016